申请人:Hoffmann-La Roche Inc.
公开号:US04652679A1
公开(公告)日:1987-03-24
Aziridine and phenethanolamine derivatives of formulae I and II-1 ##STR1## wherein R.sup.1 and R.sup.2 are hydrogen or lower-alkyl; Z.sup.1 is phenyl or a phenyl group substituted in a defined manner; Z.sup.2 and Z.sup.21 are phenyl or thienyl substituted in a defined manner; and, n is an integer from 1-4. The disclosed compounds have catabolic activity and can be used for the treatment of obesity and/or of sugar illnesses. The compounds of formula I are obtained by dehydrating .beta.-aminoalcohols (e.g. those of formula II-1) which, in turn, can be prepared by adding amines to epoxides or by reducing corresponding iminoketones, iminoalcohols a-keto-.beta.-hydroxyamines or .beta.-ketoamines.
公开的化合物具有分解代谢活性,可用于治疗肥胖症和/或糖尿病。公开的化合物的结构式I的R1和R2是氢或较低的烷基;Z1是苯基或以定义的方式取代的苯基;Z2和Z21是以定义的方式取代的苯基或噻吩基;n是1-4的整数。结构式I的化合物是通过脱水β-氨基醇(例如结构式II-1的氨基醇)获得的,而β-氨基醇则可通过向环氧化物添加胺或还原相应的亚胺酮,亚胺醇α-酮-β-羟基胺或β-酮胺制备。